Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-21

Clinical Trial Update: Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation trial evaluating iontophoretic delivery of dexamethasone phosphate for non-infectious anterior scleritis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexamethasone Phosphate (dexamethasone phosphate)

Snippet

Sponsor: John Kempen | Conditions: Non-infectious, Non-necrotizing Anterior Scleritis | Phase 1 | Status: COMPLETED